Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 May;48(5):1344-1352.
doi: 10.1161/STROKEAHA.116.014855. Epub 2017 Apr 7.

Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation)

Blanca Coll-Vinent  1 , Alfonso Martín  2 , Juan Sánchez  2 , Juan Tamargo  2 , Coral Suero  2 , Francisco Malagón  2 , Mercedes Varona  2 , Manuel Cancio  2 , Susana Sánchez  2 , José Carbajosa  2 , José Ríos  2 , Georgina Casanovas  2 , Carles Ràfols  2 , Carmen Del Arco  2 ; EMERG-AF Investigators
Collaborators, Affiliations
Observational Study

Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation)

Blanca Coll-Vinent et al. Stroke. 2017 May.

Abstract

Background and purpose: Long-term benefits of initiating stroke prophylaxis in the emergency department (ED) are unknown. We analyzed the long-term safety and benefits of ED prescription of anticoagulation in atrial fibrillation patients.

Methods: Prospective, multicenter, observational cohort of consecutive atrial fibrillation patients was performed in 62 Spanish EDs. Clinical variables and thromboprophylaxis prescribed at discharge were collected at inclusion. Follow-up at 1 year post-discharge included data about thromboprophylaxis and its complications, major bleeding, and death; risk was assessed with univariate and bivariate logistic regression models.

Results: We enrolled 1162 patients, 1024 (88.1%) at high risk according to CHA2DS2-VASc score. At ED discharge, 935 patients (80.5%) were receiving anticoagulant therapy, de novo in 237 patients (55.2% of 429 not previously treated). At 1 year, 48 (4.1%) patients presented major bleeding events, and 151 (12.9%) had died. Anticoagulation first prescribed in the ED was not related to major bleeding (hazard ratio, 0.976; 95% confidence interval, 0.294-3.236) and was associated with a decrease in mortality (hazard ratio, 0.398; 95% confidence interval, 0.231-0.686). Adjusting by the main clinical and sociodemographic characteristics, concomitant antiplatelet treatment, or destination (discharge or admission) did not affect the results.

Conclusions: Prescription of anticoagulation in the ED does not increase bleeding risk in atrial fibrillation patients at high risk of stroke and contributes to decreased mortality.

Keywords: anticoagulants; atrial fibrillation; hemorrhage; mortality stroke.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Kaplan–Meier curves showing time to first major bleeding according to anticoagulant treatment. A, All patients; B, patients who were not receiving oral anticoagulation when they arrived to the emergency department.
Figure 2.
Figure 2.
Kaplan–Meier curves showing mortality according to anticoagulant treatment. A, All patients; B, patients who were not receiving oral anticoagulation when they arrived to the emergency department.
See this image and copyright information in PMC

References

    1. McDonald AJ, Pelletier AJ, Ellinor PT, Camargo CA., Jr Increasing US emergency department visit rates and subsequent hospital admissions for atrial fibrillation from 1993 to 2004. Ann Emerg Med. 2008;51:58–65. doi: 10.1016/j.annemergmed.2007.03.007. - PubMed
    1. del Arco C, Martín A, Laguna P, Gargantilla P Investigators in the Spanish Atrial Fibrillation in Emergency Medicine Study Group (GEFAUR) Analysis of current management of atrial fibrillation in the acute setting: GEFAUR-1 study. Ann Emerg Med. 2005;46:424–430. doi: 10.1016/j.annemergmed.2005.03.002. - PubMed
    1. Coll-Vinent B, Martín A, Malagón F, Suero C, Sánchez J, Varona M, et al. HERMES-AF Investigators; HERMES-AF Investigators. Stroke prophylaxis in atrial fibrillation: searching for management improvement opportunities in the emergency department: the HERMES-AF study. Ann Emerg Med. 2015;65:1–12. doi: 10.1016/j.annemergmed.2014.07.016. - PubMed
    1. Hughes M, Lip GY Guideline Development Group, National Clinical Guideline for Management of Atrial Fibrillation in Primary and Secondary Care, National Institute for Health and Clinical Excellence. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost. 2008;99:295–304. doi: 10.1160/TH07-08-0508. - PubMed
    1. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–867. - PubMed

Publication types